United Services Automobile Association Denali Therapeutics Inc. Transaction History

United Services Automobile Association

  • $3.88 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$15.32 - $21.92 $219,351 - $313,850
-14,318 Closed
0 $0
Q2 2019

Aug 16, 2019
BUY
$18.5 - $28.14 $67,839 - $103,189
3,667 Added 34.43%
14,318 $297,000
Q4 2018

Feb 13, 2019
BUY
$13.88 - $21.75 $147,835 - $231,659
10,651 New
10,651 $220,000

Others Institutions Holding DNLI

# of Institutions
228
Shares Held
120M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.29B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email